- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Lifestyles drive radiologists into wings of nighthawks
Radiologists' wish to sleep at night and avoid call is more likely to drive demand for after-hours teleradiology services than is a need for extra personnel, according to a small survey of imaging department heads conducted by Yale University researchers.
Radiologists' wish to sleep at night and avoid call is more likely to drive demand for after-hours teleradiology services than is a need for extra personnel, according to a small survey of imaging department heads conducted by Yale University researchers.
"Convenience seems to be the dominant factor. Lifestyle issues received higher mean scores than necessity," said Adam Kaye, a Yale medical student who presented the survey findings at the 2007 American Roentgen Ray Society meeting.
Kaye's group distributed the survey among 300 randomly selected hospitals. Of those contacted, 115 responded to the 59 questions about utilization and rationales for using nighthawk-type services. Fifty-four percent of respondents reported using some degree of after-hours outsourcing. Lifestyle prerogatives were more important than cost cutting or the need to meet excess demand, according to findings.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
